ITHERA MEDICAL GMBH
Desconocido
BE-LIGHT: BE LIGHT Improving BiomEdical diagnosis through LIGHT based technologies and machine learning
ITHERA MEDICAL GMBH
participó en un
HORIZON EUROPE:
HORIZON-MSCA-2022-DN-01
Photonics is crucial for maintaining and increasing the competitiveness of EU industry, and light-based instruments are fundamental for non-...
2023-07-10 - 2027-09-30 | Financiado
2023-07-10 - 2027-09-30 | Financiado
FRONTIER: From Research Optoacoustic Novelty To Imaging Established in Routine diagnostics
ITHERA MEDICAL GMBH
tramitó un
HORIZON EUROPE:
HORIZON-EIC-2021-ACCELERATORCHALLENGES-01
Multispectral optoacoustic tomography (MSOT) is an innovative biomedical imaging technology that allows for molecular imaging in deep tissue...
2022-06-17 - 2024-03-31 | Financiado
2022-06-17 - 2024-03-31 | Financiado
SWOPT: Breaking the penetration limit of microscopy – Photoswitching Optoacoustics
ITHERA MEDICAL GMBH
participó en un
HORIZON EUROPE:
HORIZON-EIC-2021-PATHFINDEROPEN-01
SWOPT is a novel imaging technology that will break through the penetration limits of optical microscopy to visualize individual cells and t...
2022-03-15 - 2026-08-31 | Financiado
2022-03-15 - 2026-08-31 | Financiado
WINTHER: Fast optoacoustic mesoscopy using the skin as a window for therapeutic monitoring of local and syst...
ITHERA MEDICAL GMBH
participó en un
H2020:
H2020-ICT-2018-20
Optoacoustic (photoacoustic) imaging dramatically improves upon conventional bio-optic barriers and enables three-dimensional, high-resoluti...
2019-12-05 - 2024-12-31 | Financiado
2019-12-05 - 2024-12-31 | Financiado
EUPHORIA: Enhancing Ultrasound and PHOtoacoustics for Recognition of Intestinal Abnormalities
ITHERA MEDICAL GMBH
tramitó un
H2020:
H2020-EIC-FTI-2018-2020
EUPHORIA will pave the way to establish MSOT (Multispectral Optoacoustic Tomography) technology for the non-invasive assessment of intestina...
2018-12-14 - 2022-06-30 | Financiado
2018-12-14 - 2022-06-30 | Financiado
RenalToolBox: Developing novel tools and technologies to assess the safety and efficacy of cell based regenerative...
ITHERA MEDICAL GMBH
participó en un
H2020:
H2020-MSCA-ITN-2018
The RenalToolBox ITN comprises a team of world-leading clinicians, scientists and industrialists from academia and private enterprise whose...
2018-09-13 - 2023-04-30 | Financiado
2018-09-13 - 2023-04-30 | Financiado
STARSTEM: NanoSTARS imaging for STEM cell therapy for arthritic joints
ITHERA MEDICAL GMBH
participó en un
H2020:
H2020-NMBP-2016-2017
STARSTEM proposes imaging of stem cell engraftment in arthritic joints of large animals at clinically relevant depths, using nanoparticles w...
2017-10-16 - 2022-06-30 | Financiado
2017-10-16 - 2022-06-30 | Financiado
iNanoBIT: Integration of Nano and Biotechnology for beta cell and islet Transplantation
ITHERA MEDICAL GMBH
participó en un
H2020:
H2020-NMBP-2016-2017
The iNanoBIT project is aimed to apply nanotechnologies for imaging porcine pancreatic islet cellular transplants and induced pluripotent st...
2017-10-16 - 2023-03-31 | Financiado
2017-10-16 - 2023-03-31 | Financiado
FBI: Multimodal Functional Bio Photonic Imaging
ITHERA MEDICAL GMBH
participó en un
H2020:
H2020-MSCA-ITN-2016
FBI fosters education of ESRs on an emerging, multimodal imaging platform and its translation into clinical and biological applications. In...
2016-08-16 - 2021-03-31 | Financiado
2016-08-16 - 2021-03-31 | Financiado
INNODERM: Innovative Dermatology Healthcare based on Label Free Spectral Optoacoustic Mesoscopy
ITHERA MEDICAL GMBH
participó en un
H2020:
H2020-ICT-2015
Multispectral Optoacoustic Tomography (MSOT) brings a revolution to bio-optical imaging. Being insensitive to photon scattering, MSOT dramat...
2015-11-11 - 2021-08-31 | Financiado
2015-11-11 - 2021-08-31 | Financiado
PRISAR: Preclinical Intra Operative Image Guided Surgery and Post Operative Radiotherapy of Tumours
ITHERA MEDICAL GMBH
participó en un
H2020:
H2020-MSCA-RISE-2014
The main objective and basic concept of our proposal is to improve intra-operative and post-operative targeted surgical probes and new detec...
2014-12-01 - 2019-01-31 | Financiado
2014-12-01 - 2019-01-31 | Financiado
FAMOS: Functional anatomical molecular optical screening
ITHERA MEDICAL GMBH
participó en un
FP7:
Biophotonics offers low-cost, non-invasive, accurate, rapid alternatives to conventional diagnostic methods and has the potential to address...
Financiado
Financiado
* No se disponen de datos de la empresa actual.